Singapore markets closed
Straits Times Index
3,336.59 +13.21 (+0.40%) Nikkei
38,487.90 +433.77 (+1.14%) Hang Seng
18,079.61 -150.58 (-0.83%) FTSE 100
8,275.38 +44.33 (+0.54%) Bitcoin USD
67,747.33 +429.20 (+0.64%) CMC Crypto 200
1,426.08 -2.49 (-0.17%)
Ondine Biomedical Inc. (OBI.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 04:35PM BST
| Previous close | 7.75 |
| Open | 7.78 |
| Bid | 7.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 7.00 - 8.00 |
| 52-week range | 5.00 - 17.00 |
| Volume | |
| Avg. volume | 473,663 |
| Market cap | 19.41M |
| Beta (5Y monthly) | -0.01 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.06 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Ondine Biomedical’s nasal photodisinfection named as leading photonics biomedical technology for its potential to safely combat AMR
VANCOUVER, British Columbia, November 13, 2023--Ondine Biomedical’s Steriwave nasal photodisinfection technology has been shortlisted in the biomedical category of the 2024 international society for optics and photonics SPIE Prism Awards. Ondine’s nasal photodisinfection technology, which has been significantly reducing hospital acquired infections, uses a combination of a photosensitive agent and red laser light to eliminate bacteria, viruses, and fungi in the nose in minutes without generating
© 2024 Yahoo. All rights reserved.